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ABSTRACT
Pharmacokinetic/pharmacodynamic data are often analysed using nonlinear mixed-effect models,
and model evaluation should be an important part of the analysis. Recently, normalised prediction
distribution errors (npde) have been proposed as a model evaluation tool. In this paper, we describe
an add-on package for the open source statistical package R, designed to compute npde. npde take
into account the full predictive distribution of each individual observation and handle multiple ob-
servations within subjects. Under the null hypothesis that the model under scrutiny describes the
validation dataset, npde should follow the standard normal distribution. Simulations need to be per-
formed beforehand, using for example the software used for model estimation. We illustrate the use
of the package with 2 simulated datasets, one under the true model and one with different parameter
values, to show how npde can be used to evaluate models. Model estimation and data simulation were
performed using NONMEM version 5.1.
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1 Introduction
The analysis of longitudinal data is prominent in pharmacokinetic (PK) and pharmacodynamic
(PD) studies, especially during drug development [1]. Nonlinear mixed-effect models are increas-
ingly used as they are able to represent complex nonlinear processes and to describe both between
and within subject variability. The evaluation of these models is gaining importance as the field of
their application widens, ranging from dosage recommendation to clinical trial simulations [2]. Fol-
lowing the definition of Yano et al. [2]: "the goal of model evaluation is objective assessment of the
predictive ability of a model for domain-specific quantities of interest, or to determine whether the
model deficiencies (the final model is never the ‘true model’) have a noticeable effect in substantive
inferences."
Despite the recommendations of drug agencies [3, 4] stressing the importance of model evalua-
tion, a recent survey based on all published PK and/or PD analyses over the period of 2002 to 2004
shows that it is infrequently reported and often inadequately performed [5]. One possible explana-
tion is the lack of consensus concerning a proper evaluation method. Following the development
of linearisation-based approaches for the estimation of parameters in nonlinear mixed-effect models,
standardised prediction errors [6] have been widely used as diagnostic tools, not the least because they
were computed in the main software used in population PKPD analyses, NONMEM [7], where they are
reported under the name weighted residuals (WRES). However, because of the linearisation involved
in their computation there is no adequate test statistic. In 1998, Mesnil et al. proposed prediction dis-
crepancies, which were easily computed due to the discrete nature of the non-parametric distribution
estimated, to validate a PK model for mizolastine [8]. Prediction discrepancies (pd) are defined as
the percentile of an observation in the predictive distribution for that observation, under the null hy-
pothesis (H0) that the model under scrutiny adequately describes a validation dataset. The predictive
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distribution is obtained assuming the posterior distribution of the estimated parameters by maximum
likelihood estimation, disregarding the estimation error (the so-called plug-in approach [9]). By con-
struction pd follow a uniform distribution over [0,1], providing a test. In the Bayesian literature this
idea of using the whole predictive distribution for model evaluation has been proposed by Gelfand et
al [10] and is also discussed by Gelman et al [11]. Yano et al. extended this notion in a non-Bayesian
framework, proposing the approach known as Posterior Predictive Check (PPC) [2], while Holford
advocated a more visual approach under the name Visual Predictive Check (VPC) [12]. Mentré and
Escolano [13] discuss how prediction discrepancies relate to one of the three forms of PPC described
by Yano. For non-discrete distributions, Mentré and Escolano proposed to compute prediction dis-
crepancies by Monte-Carlo integration [14, 13]. In their original version, pd however did not take into
account the fact that subjects usually contributes several measurements which induces correlations be-
tween pd, leading to increased type I error. This was improved in a further work, and the uncorrelated
and normalised version of pd was termed normalised prediction distribution errors (npde) [15]. npde
have better properties than WRES, and can also be used to evaluate covariate models [16]. They can
be used for internal or external evaluation, depending on whether they are computed on the dataset
used to build the model (internal evaluation) or on an external dataset.
The computation of the npde however requires some programming. We therefore developed an
add-on package, npde, for R, the open source language and environment for statistical computing
and graphics [17], to enable easy computation of the npde [18]. Other packages such as Xpose [19],
for diagnostic and exploration, and PFIM [20, 21], for the evaluation and optimisation of population
designs, have been developed in R for the analysis of population PK and/or PD studies. Xpose is very
useful as an aid for model assessment and run management for studies performed with the NONMEM
software [7], widely used in this field but with next to no plotting capabilities, so that R was a good
choice of language for the implementation of npde.
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In section 2, we briefly recall how npde are computed. In section 3 we describe the main features
and usage of the package. In section 4 we illustrate the use of the package with two simulated
examples. The examples are simulated based on the well known dataset theophylline, available both
in R and NONMEM: the first (Vtrue) is simulated with the model used for the evaluation, while the
second (Vfalse) is simulated assuming a different set of parameters, and we show how npde can be
used to reject the model for Vfalse but not for Vtrue.
2 Computational method and theory
2.1 Models and notations
Let B denote a building (or learning) dataset and V a validation dataset (V can be the same as B for
internal evaluation). B is used to build a population model called MB. Evaluation methods compare
the predictions obtained by MB, using the design of V, to the observations in V. V can be the learning
dataset B (internal evaluation) or a different dataset (external evaluation). The null hypothesis (H0) is
that data in the validation dataset V can be described by model MB.
Let i denote the ith individual (i = 1,..., N) and j the jth measurement in an individual ( j = 1,..., ni,
where ni is the number of observations for subject i). Let ntot denote the total number of observations
(ntot = ∑i ni ). Let Yi be the ni-vector of observations observed in individual i. Let the function f
denote the nonlinear structural model. f can represent for instance the PK model. The statistical
model for the observation yi j in patient i at time ti j, is given by:
yi j = f (ti j,θi)+ εi j (1)
where θi is the vector of the individual parameters and εi j is the residual error, which is assumed to
be normal, with zero mean. The variance of εi j may depend on the predicted concentrations f (ti j,θi)
6
H
AL author m
anuscript    inserm
-00274332, version 1
through a (known) variance model. Let σ denote the vector of unknown parameters of this variance
model.
In PKPD studies for instance, it is frequently assumed that the variance of the error follows a
combined error model:
var(εi j) = σ2inter +σ
2
slope f (ti j,θi)2 (2)
where σinter and σslope are two parameters characterising the variance. In this case, σ = (σinter,σslope)′.
This combined variance model covers the case of an homoscedastic variance error model, where
σslope = 0, and the case of a constant coefficient of variation error model when σinter = 0.
Another usual assumption in PKPD analyses is that the distribution of the individual parameters
θi follows a normal distribution, or a log-normal distribution, as in:
θi = h(µ,Xi) eηi (3)
where µ is the population vector of the parameters, Xi a vector of covariates, h is a function giving the
expected value of the parameters depending on the covariates, and ηi represents the vector of random
effects in individual i. ηi usually follows a normal distribution N (0,Ω), where Ω is the variance-
covariance matrix of the random effects, but other parametric or non-parametric assumptions can be
used for the distribution of the random effects, as in the first paper proposing prediction discrepancies
in the context of non-parametric estimation [8]. Although npde were developed in the area of PK and
PD analyses, they are a general way of evaluating mixed-effect models and require only observations
and corresponding predicted distributions.
We denote P the vector of population parameters (also called hyperparameters) estimated using
the data in the learning dataset B: P = (µ′,vect(Ω)′,σ′)′, where vect(Ω) is the vector of unknown
values in Ω. Model MB is defined by its structure and by the hyperparameters ˆPB estimated from the
learning dataset B.
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2.2 Definition and computation of npde
Let Fi j denote the cumulative distribution function (cdf) of the predictive distribution of Yi j under
model MB. We define the prediction discrepancy pdi j as the value of Fi j at observation yi j, Fi j(yi j).
Fi j can be computed using Monte-Carlo simulations.
Using the design of the validation dataset V, we simulate under model MB K datasets Vsim(k)
(k=1,...,K). Let Ysim(k)i denote the vector of simulated observations for the ith subject in the kth simu-
lation.
pdi j is computed as the percentile of yi j in the empirical distribution of the y
sim(k)
i j :
pdi j = Fi j(yi j)≈
1
K
K
∑
k=1
δi jk (4)
where δi jk = 1 if ysim(k)i j < yi j and 0 otherwise.
By construction, prediction discrepancies (pd) are expected to follow U(0,1), but only in the case
of one observation per subject; within-subject correlations introduced when multiple observations are
available for each subject induce an increase in the type I error of the test [13]. To correct for this
correlation, we compute the empirical mean E(Yi) and empirical variance-covariance matrix var(Yi)
over the K simulations. The empirical mean is obtained as:
E(Yi) =
1
K
K
∑
i=1
Ysim(k)i
and the empirical variance is:
var(Yi) =
1
K−1
K
∑
i=1
(Ysim (k)i −E(Y
sim (k)
i ))(Y
sim (k)
i −E(Y
sim (k)
i ))
′
We use the var function from R to provide unbiased estimates of var(Yi).
Decorrelation is performed simultaneously for simulated data:
Ysim(k)∗i = var(Yi)
−1/2(Ysim(k)i −E(Yi))
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and for observed data:
Y∗i = var(Yi)−1/2(Yi−E(Yi))
Decorrelated pd are then obtained using the same formula as in (4) but with the decorrelated data,
and we call the resulting variables prediction distribution errors (pde):
pdei j = F∗i j(y∗i j)≈
1
K
K
∑
k=1
δ∗i jk (5)
where δ∗i jk = 1 if y
sim(k)∗
i j < y
∗
i j and 0 otherwise.
Sometimes, it can happen that some observations lie either below or above all the simulated data
corresponding to that observation. In this case, we define the corresponding pdei j as:
pdei j =


1/K if yi j < y
sim(k)
i j ∀k
1−1/K if yi j > ysim(k)i j ∀k
(6)
Under H0, if K is large enough, the distribution of the prediction distribution errors should follow
a uniform distribution over the interval [0,1] by construction of the cdf. Normalised prediction distri-
bution errors (npde) can then be obtained using the inverse function of the normal cumulative density
function implemented in most software:
npdei j = Φ−1(pdei j) (7)
By construction, if H0 is true, npde follow the N (0,1) distribution without any approximation and
are uncorrelated within an individual.
2.3 Tests and graphs
Under the null hypothesis that model MB describes adequately the data in the validation dataset,
the npde follow the N (0,1) distribution. We use 3 tests to test this assumption: (i) a Wilcoxon signed
rank test, to test whether the mean is significantly different from 0; (ii) a Fisher test for variance, to
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test whether the variance is significantly different from 1; (iii) a Shapiro-Wilks test, to test whether
the distribution is significantly different from a normal distribution. The package also reports a global
test, which consists in considering the 3 tests above with a Bonferroni correction. The p-value for
this global test is then reported as the minimum of the 3 p-values multiplied by 3 (or 1 if this value is
larger than 1) [22]. Before these tests are performed, we report the first three central moments of the
distribution of the npde: mean, variance, skewness, as well as the kurtosis, where we define kurtosis
as the fourth moment minus 3 so that the kurtosis for N (0,1) is 0 (sometimes called excess kurtosis).
The expected value of these four variables for N (0,1) are respectively 0, 1, 0 and 0. We also give
the standard errors for the mean (SE=s/√ntot) and variance (SE=s2
√
2/(ntot −1)) (where s is the
empirical variance).
Graphs can be used to visualise the shape of the distribution of the npde. The following graphs
are plotted by default: (i) QQ-plot of the npde (the line of identity is overlaid, and the npde are
expected to fall along along this line) (ii) histogram of the npde (the density line of the expected
N (0,1) is overlaid to show the expected shape), scatterplots of (iii) npde versus X and (iv) npde
versus predicted Y, where we expect to see no trend if H0 is true. For the last plot, the package
computes for each observation the predicted Y as the empirical mean over the k simulations of the
simulated predicted distribution (denoted E(ysim(k)i j )), which is reported under the name ypred along
with the npde and/or pd.
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3 Program description
3.1 Overview
The program is distributed as a add-on package or library for the free statistical software R. A
guide for the installation of R and add-on packages such as npde can be found on the CRAN (Com-
prehensive R Archive Network) at the following url: http://cran.r-project.org/. R is available free of
charge and runs on all operating systems, which made it a very convenient language for the develop-
ment of npde. The package requires only observed and simulated data to compute the npde, and does
not use the model itself.
The npde library contains 14 functions. Figure 1 presents the functions hierarchy starting with
function npde. A similar graph is obtained with function autonpde without the call to function pde-
menu.
An additional function (plotpd) can be called directly by the user to plot diagnostic graphs involv-
ing the prediction discrepancies instead of the npde, and is therefore not represented on the graph.
The functions for skewness and kurtosis were modified from the two functions of the same name
proposed in the e1071 package for R [23].
The methods described in section 2 are implemented as follows. Observed and simulated data
are read in two matrices. For each subject, the empirical mean and variance of the simulated data
are computed using the R functions mean, apply and cov. The inverse square root of the variance
matrix is obtained by the Cholesky decomposition using the functions chol and solve. The remaining
computations involve matrix and vector multiplications. All these functions are available in the R
program.
The documentation contains the simulated examples vtrue.dat and vfalse.dat, as well as the origi-
nal data file and the control files used for estimation and simulation. The simulated data simdata.dat
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used to compute the npde for both simulated datasets can be downloaded from the website.
3.2 Preparing the input
The package needs two files: the file containing the dataset to be evaluated (hereafter named ’ob-
served data’) and the file containing the simulations (hereafter named ’simulated data’). The package
does not perform the simulations. R, NONMEM [7], MONOLIX [24] or another program can be used
for that purpose, and the two following files should be prepared beforehand.
Observed data: the observed data file must contain at least the following three columns: id (patient
identification), xobs (design variable such as time, X, ...), yobs (observations such as DV, concentra-
tions, effects...). An additional column may be present in the dataset to indicate missing data (MDV).
In this case, this column should contain values of 1 to indicate missing data and 0 to indicate observed
data (as in NONMEM or MONOLIX). Alternatively, missing data can be coded using a dot (’.’) or the
character string NA directly in the column containing yobs. The computation of the npde will remove
missing observations.
Other columns may be present but will not be used by the library. The actual order of the columns
is unimportant, since the user may specify which column contain the requested information, but the
default order is 1=id, 2=xobs, 3=yobs and no MDV column. A file header may be present, and column
separators should be one of: blank space(s), tabulation mark, comma (,) or semi-colon (;).
Simulated data: the simulated data file should contain the K simulated datasets stacked one after
the other. Within each simulated dataset, the order of the observations must be the same as within the
observed dataset. The dimensions of the two datasets must be compatible: if nobs is the number of
lines in the observed dataset, the file containing the simulated datasets must have K×nobs lines. The
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simulated data file may contain a header but not repeated headers for each simulated dataset.
The simulated data file must contain at least 3 columns, in the following order: id (patient iden-
tification), xsim (independent variable), ysim (dependent variable). The column setup is fixed and
cannot be changed by the user, contrary to the observed data. Additional columns may be present
but will not be used by the package. The id column must be equal to K times the id column of the
observed dataset, and the xsim column must be equal to K times the xobs column of the observed
dataset. If missing data is present in the observed data, they should be present in the simulated datasets
and the corresponding lines will be removed for all simulated datasets during the computation.
Examples of a simulated and observed dataset are available in the subdirectory doc/inst of the
library.
BQL data: BQL (below the quantification limit LOQ) or otherwise censored data are currently
not appropriately handled by npde. If a maximum likelihood estimation method taking censored
data into account has been used for the estimation, these data should be removed from the dataset
or set to missing, using for example an MDV item, pending future extensions of npde. On the other
hand, if BQL data were set to LOQ or LOQ/2, they should remain in the dataset. npde will likely
detect model misspecification related to these data, and we suggest to remove times for which too
many observations are BQL before computing npde, since otherwise they might bias the results of
the tests. During the simulations, negative or BQL data may be simulated due to the error model. At
present, these values should be kept as is because the decorrelation step requires the whole predictive
distribution. A transform both sides approach or the use of a double exponential model can be used
to avoid simulating negative concentrations but this will not solve the BQL problem..
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3.3 Computing npde
The package provides a function called npde to enter an interactive menu where the user is
prompted to enter the names of the files and the value of the different parameters required to com-
pute npde. The menu is self-explanatory, and help pages are provided to understand the meaning of
the different parameters. Fig. 3 shows an example of using this function (text entered by the user is
shown in bold grey). The example will be detailed in section 4. The package checks the names that
are provided and prompts the user for a new name if the corresponding file cannot be found.
Optionally, pd can also be computed. Although pd do not take multiple observations into ac-
count [13], they are faster to compute than npde and can be used to perform diagnostics of model
deficiencies. Also, when computation of npde fails due to numerical difficulties, an error message is
printed and pd are computed instead (with corresponding plots). This problem can happen especially
when model adequacy is very poor.
3.4 Output
During execution, the function prints the results of the tests described in methods (section 2.3).
An example of running npde can be found in section 4.
In addition to the output printed on screen, three additional types of results are produced by
default: first, an R object containing several elements, including the npde and/or pd, is returned as
the value of the function; second, a graph file containing diagnostic plots of the npde is shown in the
graphic window and saved in a file; third, the results are saved to a text file. Options are available so
that the numerical results and graphs are not saved on disk, and so that the function returns nothing.
Let us now discuss these three outputs in more detail.
The object returned by the function contains 7 elements: (i) a data frame obsdat containing the
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observed data, with the following elements: id (patient ID), xobs (observed X) and yobs (observed
Y); (ii) ydobs: the decorrelated observed data y∗i j; (iii) ydsim: the decorrelated simulated data ysim(k)∗i j ;
(iv) ypred: the predicted value. (v) xerr: an integer (0 if no error occurred during the computation);
(vi) npde: the normalised prediction distribution errors; (vii) pd: the prediction discrepancies.
A graphic R window appears after the computation is finished, containing the 4 plots detailed in
section 2.3. These plots are saved to disk (unless boolsave=F). The name of the file is given by the
user (see Fig. 3), and an extension is added depending on the format of the graph (one of: Postscript,
JPEG, PNG or PDF, corresponding to extensions .eps, .jpeg, .png and .pdf respectively).
The results are saved in a text file with the following columns: id (patient ID), xobs (observed X),
ypred (predicted Y), npde, pd. The name of the file is the same as the name of the file in which graphs
are saved, with the extension .npde.
Sometimes the function is unable to compute the decorrelated prediction distribution errors for
one or more subjects. This failure occurs during the decorrelation step and a warning message is
printed on screen. When npde cannot be computed, the program computes automatically pd even if
the calc.pd=F option was used. In this case, diagnostic graphs are plotted (see next section) but tests
are not performed.
3.5 Other functions of interest
The npde function can be used to interactively fill in the required information. Alternatively, a
function called autonpde is provided, in which this information can be set as arguments. This function
requires 2 mandatory arguments: the name of the observed data file (or the name of the R dataframe);
and the name of the simulated data file (or the name of the R dataframe). A number of additional
optional arguments can be used to control message printing and output. These arguments and their
significance are given in Tab. 2. An example of a call to autonpde is given in section 4.
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A function called plotnpde can be used to plot the graphs described in the previous section. The
arguments for this function are the observed X, the npde and the predicted Y (ypred). The function
plotnpde is called by autonpde and npde. A similar function, plotpd, can be used to plot diagnostic
plots for the pd. These include a QQ-plot of pd versus the expected uniform U(0,1) distribution, a
histogram of the pd, and scatterplots of pd versus X and versus ypred.
The tests described in the previous section for npde can be performed using the function testnpde
(called by autonpde and npde). This function requires only the npde as argument.
4 Illustrative example
4.1 Data
To illustrate the use of the package, we simulated data based on the well known toy dataset record-
ing the pharmacokinetics of the anti-asthmatic drug theophylline. The data were collected by Upton
in 12 subjects given a single oral dose of theophylline who then contributed 11 blood samples over
a period of 25 hours [7]. We removed the data at time zero from the dataset, and applied a one-
compartment model with first-order absorption and elimination, as previously proposed [25]. The
variability was modelled using an exponential model for the interindividual variability and a com-
bined error model for the residual variability. The model was parameterised in absorption rate con-
stant ka (hr−1) volume of distribution V (L) and elimination rate constant k (hr−1) and did not include
covariates. Interindividual variability was modelled using an exponential model for the three PK pa-
rameters. A correlation between the parameters k and V was assumed (cor(ηk,ηV )). Using NONMEM
(version 5.1) with the FOCE INTERACTION estimation method, we obtained the parameter estimates
reported in Tab. 1. This model and these parameter estimates correspond to MB.
As in [15], we then simulated two external validation datasets, with the design of the real dataset:
16
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Vtrue was simulated under MB (H0), using the parameters reported in Tab. 1, while Vfalse (H1) was
simulated assuming a bioavailability divided by 2 (so that V/F is multiplied by 2). These datasets are
stored in two files called respectively vtrue.dat and vfalse.dat. Fig. 2 show plots of the concentration
versus time profiles for the two datasets.
4.2 Simulation setup
The K simulations under MB, needed to compute the npde, were also performed using NONMEM.
The control file used for the estimation was modified to set the values of the parameters (PK param-
eters, variability and error model) to the values in Tab. 1, and the number of simulations was set to
K = 2000. The simulated data were saved to a file called simdata.dat.
The simulated data describes the predicted distribution for MB, so we use it to compute the npde
for both Vtrue and Vfalse.
4.3 Computing npde for Vtrue
The function npde was used to compute the npde for the simulated dataset Vtrue, and the results
were redirected to the R object myres.true with the following command:
myres.true<-npde()
Fig. 3 shows the set of questions (in black) answered by the user (in grey).
Fig. 4 shows the output printed on screen. The first four central moments of the distribution of
the npde are first given; here they are close to the expected values for N (0,1), that is, 0 for the
mean, skewness and (excess) kurtosis and 1 for the variance. Then, the 3 tests for mean, variance
and normality, as well as the adjusted p-value for the global test, is given. Here, none of the tests
are significant. Fig. 5 shows the graphs plotted for npde. The upper left graph is a quantile-quantile
17
H
AL author m
anuscript    inserm
-00274332, version 1
plot comparing the distribution of the npde to the theoretical N (0,1) distribution, and the upper right
graph is the histogram of the npde with the density of N (0,1) overlayed. Both graphs show that the
normality assumption is not rejected. In the two lower graphs, npde are plotted against respectively
time (the independent variable X) and predicted concentrations (predicted Y). These two graphs do
not show any trend within the npde.
4.4 Computing npde for Vfalse
We now use the autonpde function to compute the npde for the second dataset, Vfalse, setting the
parameters as arguments to the function with the following command:
myres.false<-autonpde("vfalse.dat","simdata.dat",1,3,4,namesav="vfalse",
calc.pd=T)
Fig. 6 shows the output printed on screen and Fig. 7 shows the corresponding graphs. The graphs
and the Shapiro-Wilks test show that the normality assumption itself is not rejected, but the test of the
mean and variance indicate that the distribution is shifted (mean -0.45) and has an increased variance
(standard deviation 1.3) compared to N (0,1). The scatterplots in the lower part of Fig. 7 also shows
a clear pattern, with positive npde for low concentrations and negative npde for high concentrations,
reflecting model misfit.
4.5 Influence of the number of simulations
A full study of the choice of the number of simulations (K), that should be performed with respect
to the size of V, is beyond the scope of this paper. However, to assess the influence of the number
of simulations on the results, we performed a small simulation study. Because the computation of
the npde can be time-consuming, we simulated designs where all subjects have the same sampling
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times and the same dose, and thus the same predicted distribution. The dose chosen was the median
dose received by the actual patients (4.5 mg) and the 10 times were close to those observed (t={0.25,
0.5, 1, 2, 3.5, 5, 7, 9, 12, 24}). Then, we simulated the predicted distribution with K simulations
(K in {100, 200, 500, 1000, 2000, 5000}) and used the same var(Yi) and E(Yi)) to decorrelate the
vectors of observations for each simulated subject. To assess the influence of K for different designs,
we simulated four different datasets, with N=12, 100, 250 and 500 subjects respectively. One set of
simulations was performed under H0 while the other set of simulations was performed under the same
parameter assumptions as for Vfalse.
Figure 8 shows the base 10-logarithm of the p-values (log10(p)) obtained for the global test, for
the first set of simulations. The three tests (mean, variance, and normality) show the same qualitative
behaviour (data not shown). Each graph represents one simulated data set under H0 for N=12, 100,
250 and 500 subjects respectively. In the graphs, we represent log10(p) because for large number of
subjects, p-values become very small, and we jitterised the value of K by randomly adding a number
between -50 and 50, so that the points would not be superimposed. In these graphs, we observe that
small values of K are unreliable: for N=100, the scatter stabilises around K=1000, but for N=250
K=2000 appears to be necessary and even larger values should be used for N=500. When K is small
and N is large (here, N=100), we do not simulate enough concentrations to reliably describe the
predicted distribution of the concentrations, and several observed concentrations may be ascribed
the same value of npde, so that the normality test in particular often fails. When K increases, the
variability in the p-values decreases and the mean p-value stabilises, but large number of subjects
require large values of K. The program issues a warning when K is smaller than 1000, but even
that may not be sufficient when dealing with very large databases. In particular, we see that for 500
subjects with 10 observations per subject, even K=5000 may not be sufficient. Further work is needed
to give more specific recommendations.
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The second set of simulations, under H1, is shown in figure 9 for the datasets simulated with 12,
100 and 250 subjects. For the simulations with 500 subjects and some of the simulations with 250
subjects, the p-value of the test was reported as 0 due to the numerical approximation involved in
the software so we fixed an arbitrary cut-off of log10(p) = −150. The model is strongly rejected
regardless of the value of K and N. With choice of model assumptions for Vfalse therefore the value
of K has little influence in rejecting the wrong model.
5 Concluding remarks
Model evaluation is an important part of modeling. Diagnostic graphs are useful to diagnose
potential problems with models, and plots of (weighted) residuals versus independent variables or
predicted concentrations are a major part of this diagnostic. Weighted residuals are computed using
the dataset used for model estimation (internal evaluation) whereas standardised prediction errors are
computed using a different dataset (external evaluation). The shortcomings of standardised predic-
tion errors however have been publicised when improved approaches based on simulations were made
possible by the increasing computer power [13, 16]. Conditional weighted residuals have been pro-
posed recently [26] but still suffer from the approximation involved. More sophisticated approaches
now use simulations to obtain the whole predictive distribution. They include visual predictive check
(VPC), which complement traditional diagnostic graphs and improve detection of model deficien-
cies [12], as well as normalised prediction distribution errors. npde do not involve any approximation
of the model function and therefore have better properties [15].
Concerning the evaluation of the npde, the posterior distribution of the parameters is assumed to
be located only at the maximum likelihood estimate without taking into account the estimation error;
this plug-in approach was shown to be equally efficient in a very simple pharmacokinetic setting [2].
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Mentré and Escolano discuss the implications of this choice in more detail, noting in particular that
there are debates in the Bayesian literature as to whether the plug-in approach may not actually be
preferable in practice [13]. A second practical limitation consists in using a limited number of simula-
tions to compute the npde. Based on the results of the simulation study (section 4.5), we recommend
to use at least K=1000 but the actual number depends on the dataset involved, and should be increased
when the dataset includes a large number of subjects. This will be investigated in more details in fu-
ture work on npde.
Although the computation of npde is not difficult, it does require some programming ability. With
the package npde we provide a tool to compute them easily, using the validation dataset and data
simulated under the null hypothesis that model MB describes the validation dataset, with the design
of the validation dataset. A global test is performed to check whether the shape, location and variance
parameter of the distribution of the npde correspond to that of the theoretical distribution. The tests
based on npde have better properties than the tests based on pd [16], because of the decorrelation.
However, the decorrelation does not make the observations independent, except when the model is
linear so that the joint distribution of the Yi is normal. For nonlinear models such as those under study,
more work is necessary to assess the statistical properties of the tests. In addition, the normality test
appears very powerful, especially when the datasets become large. When a model is rejected, the
QQ-plots and plots of npde versus time, predictions or covariates should therefore also be considered
to assess whether, in spite of the significant p-value, the model may not be considered sufficient to
describe the data. Graphs of the pd should also be plotted when investigating model deficiencies,
since the decorrelation involved in the computation of the npde may sometimes smooth the plots and
mask model misfit, and pd can then offer additional insight.
To combine the 3 tests, the Bonferroni procedure was preferred to the previously used Simes
procedure based on the result of a simulation study, in which we found the type I error of the global
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test to be close to 5% when using a Bonferroni correction [16]. The global test with a Simes correction
can be easily computed using the p-values returned by the function testnpde(). Default diagnostic
graphs and diagnostics are also plotted to check model adequacy. Other diagnostic graphs can be
plotted, against covariates for instance, using the npde returned by the package. A current limitation
of npde concerns BQL concentrations, which the present version of npde does not handle properly.
Recently, estimation methods that handle censored data by taking into account their contribution to the
log-likelihood were implemented in Nonmem [27] and Monolix [28], making them readily available
to the general user. In the next extension to npde, we therefore plan to propose and implement a
method to handle BQL data for models using these estimation methods. In the meantime, we suggest
to remove times for which too many observations are BQL before computing npde, since otherwise
they might bias the results of the tests. A column specifying which concentrations should be removed
can be used for that purpose.
Simulations need to be performed before using the package. This was not thought to be prob-
lematic since simulations can be performed easily with the most frequently used software in the field,
NONMEM, with a minimal modification of the control file, or with MONOLIX, out of the box. The
simulations involved in the computation of npde are the same as those needed to perform VPC [12].
There is however no clear test for VPC, although testing strategies have been evaluated based on
quantiles [29], and in addition multiple observations per subject induce correlations in the VPC. On
the other hand, npde have been decorrelated, and should follow the expected standard normal distri-
bution, thus providing a one-step test of model adequacy. Another problem is that when each subject
has different doses and designs, it may be difficult to make sense of VPC. An unbalanced design
is not a problem with npde since simulations are used to obtain the predictive distribution for each
observation using the design for each individual. This makes them a kind of normalised VPC.
As a recent review points out, npde should be considered as an addition to the usual diagnostic
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metrics, and, as for all simulation-based diagnostics, care must be taken to simulate data reproducing
the design and feature of the observed data [30]. In particular, caution must be exercised when features
like BQL or missing data, dropouts, poor treatment adherence, or adaptive designs are present.
6 Availability
npde can be downloaded from http://www.npde.biostat.fr. The documentation included in the
package provides a detailed User Guide as well as an example of simulation setup, containing the
NONMEM estimation and simulation control files, the observed and simulated datasets.
npde is a package distributed under the terms of the GNU GENERAL PUBLIC LICENSE Version
2, June 1991.
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Tables
Tab. 1. Parameter estimates for the theophylline concentration dataset. A one-compartment model
was used, parameterised with the absorption rate constant ka, the volume of distribution V, and the
elimination rate constant k. A correlation between V and k (cor(ηk,ηV )) was estimated along with
the standard deviations of the three parameters. The model for the variance of the residual error is
given in equation (2).
Population mean Interindividual variability
ka (hr−1) 1.51 ωka (-) 0.67
V (L) 0.46 ωV (-) 0.12
k (hr−1) 0.087 ωk (-) 0.13
σinter (mg.L−1) 0.088 cor(ηk,ηV ) (-) 0.99
σslope (-) 0.26
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Tab. 2. Options available for the autonpde function.
Option Effect Default value
iid column with ID in the observed data file 1
ix column with X in the observed data file 2
iy column with Y in the observed data file 3
imdv column with MDV in the observed data file 0 (none)
namsav name of the file where results will be saved
(without extension)
output
boolsave whether results should be saved to disk T
type.graph graph format (one of PDF, postscript, eps
JPEG or PNG)1 (postscript)
output whether the function returns the results T
verbose whether a message should be printed as the
computation of npde begins in a new subject
F
calc.npde whether normalised prediction distribution er-
rors should be computed
T
calc.pd whether prediction discrepancies should be
computed
F
1 JPEG and PNG format are only available if the version of R used has been built to enable JPEG
and PNG output. If this is not the case, and the user selects JPEG or PNG format, the program will
automatically switch to PDF and a warning will be printed.
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LEGENDS FOR FIGURES
Fig.1. Function hierarchy for the npde library, and brief description of each function. The functional
hierarchy is given for a user call to npde. With autonpde, the hierarchy is the same save for the initial
call to pdemenu.
Fig.2. Concentration versus time data for the two simulated datasets Vtrue (left) and Vfalse (right).
Fig.3. Example of a call to the function npde, where user input is shown in bold grey.
Fig.4. Output of the function npde applied to dataset Vtrue.
Fig.5. Graphs plotted for Vtrue. Quantile-quantile plot of npde versus the expected standard normal
distribution (upper left). Histogram of npde with the density of the standard normal distribution
overlayed (upper right). Scatterplot of npde versus observed X (lower left). Scatterplot of npde
versus ypred (lower right).
Fig.6. Output of the function npde applied to dataset Vfalse
Fig.7. Graphs plotted for Vfalse. Quantile-quantile plot of npde versus the expected standard normal
distribution (upper left). Histogram of npde with the density of the standard normal distribution
overlayed (upper right). Scatterplot of npde versus observed X (lower left). Scatterplot of npde
versus ypred (lower right).
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Fig.8. Influence of the number of simulations (K) on the p-value, represented as log10(p), of the
global test under H0, for 4 simulated datasets with respectively 12, 100, 250 and 500 subjects. In each
graph, the solid line represents the median of the 10 simulations (×) performed for each value of K.
A dotted line is plotted for y=log10(0.05).
Fig.9. Influence of the number of simulations (K) on the p-value, represented as log10(p), of the
global test under H1, for 4 simulated datasets with respectively 12, 100, 250 and 500 subjects. In each
graph, the solid line represents the median of the 10 simulations (×) performed for each value of K.
A dotted line is plotted for y=log10(0.05).
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Figures
Fig. 1
plot graphs
save graphs to file
compute npde in one subject
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Fig. 3
Name of the file containing the observed data: vtrue.dat
I’m assuming file vtrue.dat has the following structure:
ID X Y ...
and does not contain a column signaling missing data.
To keep, press ENTER, to change, type any letter: n
Column with ID information? 1
Column with X (eg time) information? 3
Column with Y (eg DV) information? 4
Column signaling missing data (eg MDV, press ENTER if none)?
Name of the file containing the simulated data: simdata.dat
Do you want results and graphs to be saved to files (y/Y) [default=yes]? y
Different formats of graphs are possible:
1. Postscript (extension eps)
2. JPEG (extension jpeg)
3. PNG (extension png)
4. Acrobat PDF (extension pdf)
Which format would you like for the graph (1-4)? 1
Name of the file (extension will be added, default=output): vtrue
Do you want to compute npde (y/Y) [default=yes]? y
Do you want to compute pd (y/Y) [default=no]? y
Do you want a message printed as the computation of npde begins in a new
subject (y/Y) [default=no]? n
Do you want the function to return an object (y/Y) [default=yes]? y
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Fig. 4
Computing npde
Saving graphs in file vtrue.eps
------------------------------
Distribution of npde:
mean= -0.09442 (SE= 0.092)
variance= 1.006 (SE= 0.13)
skewness= -0.1048
kurtosis= -0.1783
------------------------------
Statistical tests
Wilcoxon signed rank test : 0.35
Fisher variance test : 0.931
SW test of normality : 0.839
Global adjusted p-value : 1
--
Signif. codes: ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’ 0.1
------------------------------
Saving results in file vtrue.npde
Computing pd
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Fig. 6
Computing npde
Saving graphs in file vfalse.eps
------------------------------
Distribution of npde:
mean= -0.4525 (SE= 0.12 )
variance= 1.748 (SE= 0.23 )
skewness= 0.3359
kurtosis= -0.4629
------------------------------
Statistical tests
Wilcoxon signed rank test : 0.000285 ***
Fisher variance test : 1.65e-06 ***
SW test of normality : 0.141
Global adjusted p-value : 4.96e-06 ***
--
Signif. codes: ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’ 0.1
------------------------------
Computing pd
Saving results in file vfalse.npde
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Fig. 7
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Fig. 8
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Fig. 9
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